|
|
||||||||
Breast Imaging |
1 From the Departments of Radiology (C.K.K., C.C.L., H.H.S.), Gynecology and Gynecologic Oncology (R.K.S., A.K., A.H., D.K.), Pathology (E.W., U.P.), and Human Genetics (M.M.), University of Bonn Medical Center, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany. Received November 2, 1998; revision requested December 17; final revision received August 30, 1999; accepted September 14. C.K.K., R.K.S. supported in part by a grant from the Deutsche Krebshilfe, and C.K.K. supported in part by a grant from the Förderverein Radiologie an der Universität Bonn. Address reprint requests to C.K.K.
PURPOSE: To compare magnetic resonance (MR) imaging with conventional imaging in screening high-risk women.
MATERIALS AND METHODS: This prospective trial included 192 asymptomatic and six symptomatic women who, on the basis of personal or family history or genetic analysis, were suspected or proved to carry a breast cancer susceptibility gene.
RESULTS: Fifteen breast cancers were identified: nine in the 192 asymptomatic women (six in the first and three in the second screening round) and six in the symptomatic patients. Concerning the asymptomatic women, four of the nine breast cancers were detected and correctly classified with mammography and ultrasonography (US) combined; another two cancers were visible as well-circumscribed masses and were diagnosed as fibroadenomas. MR imaging allowed the correct classification and local staging of all nine cancers. In 105 asymptomatic women with validation of the 1st-year screening results, the sensitivities of mammography, US, and MR imaging were 33%, 33% (mammography and US combined, 44%), and 100%, respectively; the positive predictive values were 30%, 12%, and 64%, respectively.
CONCLUSION: The accuracy of MR imaging is significantly higher than that of conventional imaging in screening high-risk women. Difficulties can be caused by an atypical manifestation of hereditary breast cancers at both conventional and MR imaging and by contrast material enhancement associated with hormonal stimulation.
Index terms: Breast, MR, 00.121412, 00.12143 Breast neoplasms, diagnosis, 00.30, 00.311, 00.32 Breast neoplasms, MR, 00.121412, 00.12143 Breast neoplasms, radiography, 00.11 Breast neoplasms, US, 00.1298 Cancer screening Genes and genetics
This article has been cited by other articles:
![]() |
J. M. Lee, D. B. Kopans, P. M. McMahon, E. F. Halpern, P. D. Ryan, M. C. Weinstein, and G. S. Gazelle Breast Cancer Screening in BRCA1 Mutation Carriers: Effectiveness of MR Imaging--Markov Monte Carlo Decision Analysis Radiology, March 1, 2008; 246(3): 763 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schrading and C. K. Kuhl Mammographic, US, and MR Imaging Phenotypes of Familial Breast Cancer Radiology, January 1, 2008; 246(1): 58 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kim, E.-K. Kim, J. Y. Kwak, B.-W. Park, S.-I. Kim, and K. K. Oh Bilateral Synchronous Breast Cancer in an Asian Population: Mammographic and Sonographic Characteristics, Detection Methods, and Staging Am. J. Roentgenol., January 1, 2008; 190(1): 208 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Javid, J. W. Carlson, J. E. Garber, R. L. Birdwell, S. Lester, S. Lipsitz, and M. Golshan Breast MRI Wire-Guided Excisional Biopsy: Specimen Size as Compared to Mammogram Wire-Guided Excisional Biopsy and Implications for Use. Ann. Surg. Oncol., December 1, 2007; 14(12): 3352 - 3358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kuhl Current Status of Breast MR Imaging * Part 2. Clinical Applications Radiology, September 1, 2007; 244(3): 672 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kuhl The Current Status of Breast MR Imaging * Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice Radiology, August 1, 2007; 244(2): 356 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Lehman, C. Isaacs, M. D. Schnall, E. D. Pisano, S. M. Ascher, P. T. Weatherall, D. A. Bluemke, D. J. Bowen, P. K. Marcom, D. K. Armstrong, et al. Cancer Yield of Mammography, MR, and US in High-Risk Women: Prospective Multi-Institution Breast Cancer Screening Study Radiology, August 1, 2007; 244(2): 381 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mesurolle, L. Kadoch, M. El-Khoury, A. Lisbona, N. Dendukuri, and W. D. Foulkes Sonographic Features of Breast Carcinoma Presenting as Masses in BRCA Gene Mutation Carriers J. Ultrasound Med., June 1, 2007; 26(6): 817 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Port, A. Park, P. I. Borgen, E. Morris, and L. L. Montgomery Results of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia Ann. Surg. Oncol., March 1, 2007; 14(3): 1051 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography CA Cancer J Clin, March 1, 2007; 57(2): 75 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sardanelli, F. Podo, G. D'Agnolo, A. Verdecchia, M. Santaquilani, R. Musumeci, G. Trecate, S. Manoukian, S. Morassut, C. de Giacomi, et al. Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results Radiology, March 1, 2007; 242(3): 698 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Macura, R. Ouwerkerk, M. A. Jacobs, and D. A. Bluemke Patterns of Enhancement on Breast MR Images: Interpretation and Imaging Pitfalls RadioGraphics, November 1, 2006; 26(6): 1719 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zabicki, J. A. Colbert, F. J. Dominguez, M. A. Gadd, K. S. Hughes, J. L. Jones, M. C. Specht, J. S. Michaelson, and B. L. Smith Breast Cancer Diagnosis in Women <= 40 versus 50 to 60 Years: Increasing Size and Stage Disparity Compared With Older Women Over Time Ann. Surg. Oncol., August 1, 2006; 13(8): 1072 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bradbury and O. I. Olopade The Case for Individualized Screening Recommendations for Breast Cancer J. Clin. Oncol., July 20, 2006; 24(21): 3328 - 3330. [Full Text] [PDF] |
||||
![]() |
C. D. Lehman, S. Peacock, W. B. DeMartini, and X. Chen A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity. Am. J. Roentgenol., July 1, 2006; 187(1): 51 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kuhl, P. Jost, N. Morakkabati, O. Zivanovic, H. H. Schild, and J. Gieseke Contrast-enhanced MR Imaging of the Breast at 3.0 and 1.5 T in the Same Patients: Initial Experience Radiology, June 1, 2006; 239(3): 666 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Plevritis, A. W. Kurian, B. M. Sigal, B. L. Daniel, D. M. Ikeda, F. E. Stockdale, and A. M. Garber Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA, May 24, 2006; 295(20): 2374 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
G J Heyes, A J Mill, and M W Charles Enhanced biological effectiveness of low energy X-rays and implications for the UK breast screening programme. Br. J. Radiol., March 1, 2006; 79(939): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Schnall, J. Blume, D. A. Bluemke, G. A. DeAngelis, N. DeBruhl, S. Harms, S. H. Heywang-Kobrunner, N. Hylton, C. K. Kuhl, E. D. Pisano, et al. Diagnostic Architectural and Dynamic Features at Breast MR Imaging: Multicenter Study Radiology, January 1, 2006; 238(1): 42 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morakkabati-Spitz, H. H. Schild, C. C. Leutner, M. von Falkenhausen, G. Lutterbey, and C. K. Kuhl Dynamic Contrast-enhanced Breast MR Imaging in Men: Preliminary Results Radiology, December 21, 2005; (2005) 2382041312. [Abstract] [Full Text] |
||||
![]() |
C. L. Buchanan, E. A. Morris, P. L. Dorn, P. I. Borgen, and K. J. Van Zee Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer Ann. Surg. Oncol., December 1, 2005; 12(12): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kuhl, S. Schrading, C. C. Leutner, N. Morakkabati-Spitz, E. Wardelmann, R. Fimmers, W. Kuhn, and H. H. Schild Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer J. Clin. Oncol., November 20, 2005; 23(33): 8469 - 8476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malich, D. R. Fischer, S. Wurdinger, J. Boettcher, C. Marx, M. Facius, and W. A. Kaiser Potential MRI Interpretation Model: Differentiation of Benign from Malignant Breast Masses Am. J. Roentgenol., October 1, 2005; 185(4): 964 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. L. Warren, L. Pointon, D. Thompson, R. Hoff, F. J. Gilbert, A. Padhani, D. Easton, S. R. Lakhani, M. O. Leach, and For the UK Magnetic Resonance Imaging in Breast Sc Reading Protocol for Dynamic Contrast-enhanced MR Images of the Breast: Sensitivity and Specificity Analysis Radiology, September 1, 2005; 236(3): 779 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kuhl, H. H. Schild, and N. Morakkabati Dynamic Bilateral Contrast-enhanced MR Imaging of the Breast: Trade-off between Spatial and Temporal Resolution Radiology, September 1, 2005; 236(3): 789 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Lehman, E. R. DePeri, S. Peacock, M. D. McDonough, W. B. DeMartini, and J. Shook Clinical Experience with MRI-Guided Vacuum-Assisted Breast Biopsy Am. J. Roentgenol., June 1, 2005; 184(6): 1782 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Kurian, M. A. Mills, M. Jaffee, B. M. Sigal, N. M. Chun, K. E. Kingham, L. C. Collins, K. W. Nowels, S. K. Plevritis, J. E. Garber, et al. Ductal Lavage of Fluid-Yielding and Non-Fluid-Yielding Ducts in BRCA1 and BRCA2 Mutation Carriers and Other Women at High Inherited Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1082 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hylton Magnetic Resonance Imaging of the Breast: Opportunities to Improve Breast Cancer Management J. Clin. Oncol., March 10, 2005; 23(8): 1678 - 1684. [Full Text] [PDF] |
||||
![]() |
J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher Screening for Breast Cancer JAMA, March 9, 2005; 293(10): 1245 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer Am. J. Roentgenol., March 1, 2005; 184(3): 868 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sardanelli, F. Podo, and L. E. Philpotts Women with History of Breast Cancer Excluded from Screening Programs: Is It the Right Choice? * Dr Philpotts responds: Radiology, March 1, 2005; 234(3): 971 - 972. [Full Text] [PDF] |
||||
![]() |
E. E. Deurloo, S. H. Muller, J. L. Peterse, A. P. E. Besnard, and K. G. A. Gilhuijs Clinically and Mammographically Occult Breast Lesions on MR Images: Potential Effect of Computerized Assessment on Clinical Reading Radiology, March 1, 2005; 234(3): 693 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morrow Magnetic Resonance Imaging in Breast Cancer: One Step Forward, Two Steps Back? JAMA, December 8, 2004; 292(22): 2779 - 2780. [Full Text] [PDF] |
||||
![]() |
R. Sifri, S. Gangadharappa, and L. S. Acheson Identifying and Testing for Hereditary Susceptibility to Common Cancers CA Cancer J Clin, November 1, 2004; 54(6): 309 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Warner, D. B. Plewes, K. A. Hill, P. A. Causer, J. T. Zubovits, R. A. Jong, M. R. Cutrara, G. DeBoer, M. J. Yaffe, S. J. Messner, et al. Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination JAMA, September 15, 2004; 292(11): 1317 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kriege, C. T.M. Brekelmans, C. Boetes, P. E. Besnard, H. M. Zonderland, I. M. Obdeijn, R. A. Manoliu, T. Kok, H. Peterse, M. M.A. Tilanus-Linthorst, et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition N. Engl. J. Med., July 29, 2004; 351(5): 427 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liberman Breast Cancer Screening with MRI -- What Are the Data for Patients at High Risk? N. Engl. J. Med., July 29, 2004; 351(5): 497 - 500. [Full Text] [PDF] |
||||
![]() |
J. E. Garber and A.-R. Hartman Prophylactic Oophorectomy and Hormone Replacement Therapy: Protection at What Price? J. Clin. Oncol., March 15, 2004; 22(6): 978 - 980. [Full Text] [PDF] |
||||
![]() |
D. B. Kopans Sonography Should Not Be Used for Breast Cancer Screening Until Its Efficacy Has Been Proven Scientifically Am. J. Roentgenol., February 1, 2004; 182(2): 489 - 491. [Full Text] [PDF] |
||||
![]() |
F. Graziano, B. Humar, and P. Guilford The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice Ann. Onc., December 1, 2003; 14(12): 1705 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
A R Padhani MRI for assessing antivascular cancer treatments Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Mincey Genetics and the Management of Women at High Risk for Breast Cancer Oncologist, October 1, 2003; 8(5): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Morris, L. Liberman, D. J. Ballon, M. Robson, A. F. Abramson, A. Heerdt, and D. D. Dershaw MRI of Occult Breast Carcinoma in a High-Risk Population Am. J. Roentgenol., September 1, 2003; 181(3): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Teifke, H. A. Lehr, T. W. Vomweg, A. Hlawatsch, and M. Thelen Outcome Analysis and Rational Management of Enhancing Lesions Incidentally Detected on Contrast-Enhanced MRI of the Breast Am. J. Roentgenol., September 1, 2003; 181(3): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Jong, M. J. Yaffe, M. Skarpathiotakis, R. S. Shumak, N. M. Danjoux, A. Gunesekara, and D. B. Plewes Contrast-enhanced Digital Mammography: Initial Clinical Experience Radiology, September 1, 2003; 228(3): 842 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. LaTrenta, J. H. Menell, E. A. Morris, A. F. Abramson, D. D. Dershaw, and L. Liberman Breast Lesions Detected with MR Imaging: Utility and Histopathologic Importance of Identification with US Radiology, June 1, 2003; 227(3): 856 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Berg Rationale for a Trial of Screening Breast Ultrasound: American College of Radiology Imaging Network (ACRIN) 6666 Am. J. Roentgenol., May 1, 2003; 180(5): 1225 - 1228. [Full Text] [PDF] |
||||
![]() |
L. Liberman, E. A. Morris, D. D. Dershaw, A. F. Abramson, and L. K. Tan MR Imaging of the Ipsilateral Breast in Women with Percutaneously Proven Breast Cancer Am. J. Roentgenol., April 1, 2003; 180(4): 901 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liberman, E. A. Morris, C. M. Kim, J. B. Kaplan, A. F. Abramson, J. H. Menell, K. J. Van Zee, and D. D. Dershaw MR Imaging Findings in the Contralateral Breast of Women with Recently Diagnosed Breast Cancer Am. J. Roentgenol., February 1, 2003; 180(2): 333 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Neubauer, M Li, R Kuehne-Heid, A Schneider, and W A Kaiser High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement Br. J. Radiol., January 1, 2003; 76(901): 3 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Roukos, N. J. Agnanti, E. Paraskevaidis, and A. M. Kappas Approaching the Dilemma Between Prophylactic Bilateral Mastectomy or Oophorectomy for Breast and Ovarian Cancer Prevention in Carriers of BRCA1 or BRCA2 Mutations Ann. Surg. Oncol., December 1, 2002; 9(10): 941 - 943. [Full Text] [PDF] |
||||
![]() |
K. G. A. Gilhuijs, E. E. Deurloo, S. H. Muller, J. L. Peterse, and L. J. Schultze Kool Breast MR Imaging in Women at Increased Lifetime Risk of Breast Cancer: Clinical System for Computerized Assessment of Breast Lesions—Initial Results Radiology, December 1, 2002; 225(3): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Moon, D.-Y. Noh, and J.-G. Im Multifocal, Multicentric, and Contralateral Breast Cancers: Bilateral Whole-Breast US in the Preoperative Evaluation of Patients Radiology, August 1, 2002; 224(2): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Morris, L. Liberman, D. D. Dershaw, J. B. Kaplan, L. R. LaTrenta, A. F. Abramson, and D. J. Ballon Preoperative MR Imaging--Guided Needle Localization of Breast Lesions Am. J. Roentgenol., May 1, 2002; 178(5): 1211 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Goffin, P. O. Chappuis, N. Wong, and W. D. Foulkes Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1754 - 1754. [Full Text] [PDF] |
||||
![]() |
M. J. Stoutjesdijk, C. Boetes, and J. O. Barentsz RESPONSE: Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1755 - 1755. [Full Text] [PDF] |
||||
![]() |
S. Narod, K. Offit, M. Robson, D. Schrag, T. Riggs, M. J. Stoutjesdijk, J. O. Barentsz, J. G.M. Klijn, and H. Meijers-Heijboer Prophylactic Mastectomy in Carriers of BRCA Mutations N. Engl. J. Med., November 15, 2001; 345(20): 1498 - 1500. [Full Text] [PDF] |
||||
![]() |
E. Warner, D. B. Plewes, R. S. Shumak, G. C. Catzavelos, L. S. Di Prospero, M. J. Yaffe, V. Goel, E. Ramsay, P. L. Chart, D. E.C. Cole, et al. Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer J. Clin. Oncol., August 1, 2001; 19(15): 3524 - 3531. |